Skip to content
Profiles

Vincent Timmerman, PhD

University of Antwerp
Antwerp, Belgium
Professor

Dr. Vincent Timmerman’s lab studies the effect of CMT causing mutations in neuronal and non-neuronal cells, including neurons and muscle cells differentiated from human induced pluripotent stem cells. The molecular biology of gene mutations, compared with clinical, physiological and pathological data from CMT patients, contributes to genotype-phenotype correlations. We gain knowledge using various gene-cloning technologies and have generated mouse and Drosophila models of CMT and related neuropathies. Our recent development of human-derived organoids and neuromuscular assembloids complements the animal, cellular and molecular models and allows the study of disease mechanisms relevant to inherited sensory and/or motor neuropathies.

Portrait of Vincent Timmerman, PhD, wearing tortoiseshell round glasses and a navy blazer, posed against a neutral gray backdrop for a professional headshot.

Joined

2026

Therapy Type

Small Molecules; RNA Interference; CRISPR Editing

Demyelinating and Axonal CMT (HMSN); Distal Hereditary Motor Neuropathies (HMN); Sensory Neuropathies (HSAN, HSAN-I). With a focus in: CMT1A; CMT2F/dHMN; CMT2L; and CMT2JJ.